Spinal Stenosis: Clinical Trials

7 trials for Spinal Stenosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 terminated, 1 withdrawn. 7 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 4, Recruiting 1, Terminated 1, Withdrawn 1
Phase 25Completed 4, Withdrawn 1

Follow Spinal Stenosis: new trials by email Literature Review of Spinal Stenosis trials Research Report on Spinal Stenosis

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury
EC5026 oral tablet, Placebo oral tablet - Spinal Cord Injuries, Neuropathic Pain
Phase 1RecruitingEicOsis Human Health Inc.362026-05-012026-07-10
Sterile Amniotic Fluid Filtrate Epidural Injection.
Amniotic Fluid Allograft, Dexamethasone sodium phosphate - Lumbar Spinal Stenosis
Phase 1 / Phase 2CompletedUniversity of Utah582021-06-162026-09-25
First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)
AK1320 MS, Control - Degenerative Spondylolisthesis, Spinal Stenosis
Phase 1TerminatedAsahi Kasei Therapeutics Corporation302020-11-182024-03-06
Cognitive-Behavioral Physical Therapy
CBPT, Control-Attention - Spinal Stenosis
Phase 1 / Phase 2CompletedVanderbilt University862012-02-012014-07-04
Safety and Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and Fusion
NeoFuse, MasterGraft Granules - Cervical Degenerative Disc Disease, Degenerative Spondylolisthesis
Phase 1 / Phase 2CompletedMesoblast, Ltd.122010-06-012020-06-29
Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion
PLF with autograft, PLF with NeoFuse - Degenerative Disc Disease, Degenerative Spondylolisthesis
Phase 1 / Phase 2WithdrawnMesoblast, Ltd.2008-11-012020-06-02
Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF)
NeoFuse, posterolateral spinal fusion with instrumentation - Degenerative Disc Disease, Spondylolisthesis
Phase 1 / Phase 2CompletedMesoblast, Ltd.62007-10-012020-06-29

Narrower conditions

Intervertebral Disc Degeneration (3)  ·  Spondylolisthesis (2)  ·  Neuralgia (1)  ·  Spinal Cord Injuries (1)  ·  Spondylosis (1)

Broader conditions

Bone Diseases (7)  ·  Musculoskeletal Diseases (7)  ·  Spinal Diseases (7)  ·  Spondylolysis (2)  ·  Spondylosis (2)  ·  Central Nervous System Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Diseases (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Peripheral Nervous System Diseases (1)  ·  Signs and Symptoms (1)  ·  Spinal Cord Diseases (1)  ·  Trauma, Nervous System (1)

Interventions

Spinal Fusion (2)  ·  Dexamethasone (1)  ·  EC5026 (1)  ·  Gene Fusion (1)  ·  Transplantation, Autologous (1)  ·  dexamethasone 21-phosphate (1)

Sponsors

Mesoblast, Ltd. (3)  ·  Asahi Kasei Therapeutics Corporation (1)  ·  EicOsis Human Health Inc. (1)  ·  University of Utah (1)  ·  Vanderbilt University (1)

Countries

United States (5)  ·  Australia (1)  ·  Canada (1)

Top investigators

Donna Skerrett, MD (2)  ·  Kristin Archer, PhD (1)  ·  Roger Brown (1)  ·  William K Schmidt, PhD (1)  ·  Zachary L McCormick, MD (1)

Results publications

PMID 41915069